Isoliquiritigenin limits inflammasome activation of macrophage via docking into Syk to alleviate murine non‐alcoholic fatty liver diseaseXiangyu Hu, Weijuan Gong, Liting Liao et al.|Scandinavian Journal of Immunology|2024Cited by 5